STEAD

Welcome to the Brand page for “STEAD”, which is offered here for Conducting early evaluations in the field of new pharmaceuticals; research and development of pharmaceutical and biopharmaceutical preparations and medicines; pharmaceutical and biotechnology products development; research and development in the pharmaceutical and biotechnology fields; pharmaceutical and biopharmaceutical research services in the fields of cancer and genetic diseases; pharmaceutical and biopharmaceutical research services in the nature of biomarker identification; pharmaceutical and biopharmaceutical research services, artificial intelligence assisted drug discovery and development services; software as a service (saas) services featuring artificial intelligence software for drug discovery and development; platform as a service services (paas) featuring computer software platforms for drug development and discovery;.

Its status is currently believed to be active. Its class is unavailable. “STEAD” is believed to be currently owned by “GV20 Therapeutics LLC”.

Owner:
GV20 THERAPEUTICS LLC
Owner Details
Description:
Conducting early evaluations in the field of new pharmaceuticals; research and development of pharmaceutical and biopharmaceutical preparations and medicines; Pharmaceutical and biotechnology products development; Research and development in the pharmaceutical and biotechnology fields; pharmaceutical and biopharmaceutical research services in the fields of cancer and genetic diseases; pharmaceutical and biopharmaceutical research services in the nature of biomarker identification; pharmaceutical and biopharmaceutical research services, artificial intelligence assisted drug discovery and development services; software as a service (SAAS) services featuring artificial intelligence software for drug discovery and development; platform as a service services (PAAS) featuring computer software platforms for drug development and discovery;
Categories: CONDUCTING EARLY EVALUATIONS